|
Phase I |
Radiolabeled Monoclonal Antibody Therapy Combined With Total-Body Irradiation, Allogeneic Peripheral Stem Cell Transplantation, and Immunosuppression Therapy in Treating Older Patients Who Have Advanced Acute Myeloid Leukemia, Myelodysplastic Syndrome, or |
2009-05-20 |
|
Phase III |
Memantine in Preventing Side Effects in Patients Undergoing Whole-Brain Radiation Therapy for Brain Metastases From Solid Tumors |
2009-05-20 |
|
Phase I |
A Phase I Dose-Escalation Study of BMS-641988 in Patients With Castration-Resistant Prostate Cancer |
2009-05-20 |
|
Phase III |
Selenium in Preventing Tumor Growth in Patients With Previously Resected Stage I Non-Small Cell Lung Cancer |
2009-05-20 |
|
Phase I |
Safety Study of EMD 72000 in Combination With ECX (Epirubicin, Cisplatin and Capecitabine) in Oesophagogastric Cancer |
2009-05-20 |
|
Phase III |
A Companion Study for Patients Enrolled in Prior/Parent Ipilimumab Studies |
2009-05-20 |
|
Phase II |
Safety and Efficacy of Abatacept Versus Placebo in Subjects With Psoriatic Arthritis |
2009-05-20 |
|
Phase II |
Radiation Therapy, Androgen Suppression, and Docetaxel in Treating Patients With High-Risk Prostate Cancer Who Have Undergone Radical Prostatectomy |
2009-05-20 |
|
Phase II |
Study of Zoladex Given Every 12 Weeks Versus Given Every Month in Advanced Breast Cancer (ABC) Pre-Menopausal Women |
2009-05-20 |
|
Phase II |
Phase II Study of Dasatinib (BMS-354825) for Androgen-Deprived Progressive Prostate Cancer |
2009-05-20 |
|
Phase III |
Study of Apixaban for the Prevention of Thrombosis-Related Events in Patients With Acute Medical Illness |
2009-05-20 |
|
Phase IV |
A Post-Marketing Clinical Study of Apligraf for Venous Leg Ulcers |
2009-05-20 |
|
Phase III |
Comparison of Fulvestrant (FASLODEXâ„¢) 250 mg and 500mg in Postmenopausal Women With Oestrogen Receptor Positive Advanced Breast Cancer Progressing or Relapsing After Previous Endocrine Therapy. |
2009-05-20 |
|
|
Usefulness of Nasal Continuous Positive Airway Pressure (CPAP) Treatment in Patients With a First Ever Stroke and Sleep Apnea Syndrome |
2009-05-20 |
|
Phase II |
A Phase II Combination of Trastuzumab and Ixabepilone Versus Trastuzumab and Docetaxel in Patients With Advanced and/or Metastatic Breast Cancer |
2009-05-20 |
|
Phase II |
Phase II Trial of Weekly or Every 3-Week Ixabepilone for Patients With Metastatic Breast Cancer (MBC) |
2009-05-20 |
|
Phase I |
A Study of Dasatinib in Chronic Phase Philadelphia Chromosome Positive Chronic Myeloid Leukemia |
2009-05-20 |
|
Phase III |
Efficacy and Safety Study of Abatacept to Treat Lupus Nephritis |
2009-05-20 |
|
|
A Belatacept Compassionate Use Study for Patients With a Kidney Transplant |
2009-05-20 |
|
Phase II |
A Phase II, Trial of Ixabepilone Plus Cetuximab as First Line Therapy for Metastatic Pancreatic Cancer |
2009-05-20 |
|
Phase I |
Phase I Study of Dasatinib (BMS-354825) and Capecitabine for Women With Advanced Breast Cancer |
2009-05-20 |
|
Phase I |
A Phase I Study to Determine the Effect of Food on Brivanib (BMS-582664) |
2009-05-20 |
|
Phase III |
Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer |
2009-05-20 |
|
Phase I |
Multiple Dose Study In Cancer Patients: Safety and Tolerability of BMS-754807 in Advanced or Metastatic Solid Tumors |
2009-05-20 |
|
Phase I |
A Study of BMS-582664 in Patients With Advanced or Metastatic Solid Tumors |
2009-05-20 |